# Springvest

> Springvest is a VC fund in Helsinki backing Biotechnology and Health Care. See 23 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Helsinki, Finland
- Total investments: 23
- Last investment: Nov 2025
- Lead investor: 74%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/springvest
- Website: https://www.springvest.fi/

Springvest is a VC fund in Helsinki focused on Biotechnology and Health Care. The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.

## Contacts

5 contacts available for Springvest. Shizune tracks 4 team members at Springvest. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/springvest?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.6M–$7.6M |
| Series A | $3.6M–$53M |
| Venture - Series Unknown | $9.1M–$29M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 7 | 30% |
| Health Care | 5 | 22% |
| Medical | 3 | 13% |
| Analytics | 3 | 13% |
| Artificial Intelligence | 3 | 13% |

31 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 12 | 52% |
| Seed | 2 | 9% |
| Venture - Series Unknown | 2 | 9% |
| Series B | 1 | 4% |
| Series C | 1 | 4% |

8 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Aki Soudunsaari | CEO | 1 | https://shizune.co/investors/profile/aki-soudunsaari |
| Jouni Mäkelä | Investment Director | 1 | https://shizune.co/investors/profile/jouni-m%C3%A4kel%C3%A4 |
| Markku Jussila | Co-Founder & Director | 0 | https://shizune.co/investors/profile/markku-jussila-5fee |
| Päivi Malinen | Chief Executive Officer | 0 | https://shizune.co/investors/profile/p%C3%A4ivi-malinen |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MedicubeX | MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location. | $3.9M | Equity Crowdfunding | Nov 06, 2025 |  |
| ReOrbit | Founded in 2019 and headquartered in Helsinki, Finland, ReOrbit is a fast-growing European space technology company that manufactures sovereign satellites and connected systems for national security. Our technologies provide independent control of critical space assets and enable secure communications for both military and civilian use. Throughlong-term partnerships and knowledge transfer, we ensure our customers achieve and maintain strategic autonomy.With offices across multiple countries, we bring together a diverse team of experts who bring extensive industry experience and technical excellence to our operations. As we continue to expand, we are opening new locations worldwide and are always on the lookout for talented, ambitious individuals to join our journey. | $53M | Series A | Sep 08, 2025 |  |
| Volare | Sustainable high-quality protein and lipid ingredients for the industry from local raw materials | $29.5M | Venture - Series Unknown | May 27, 2025 |  |
| Volare | Sustainable high-quality protein and lipid ingredients for the industry from local raw materials | $6.8M | Series A | Oct 11, 2024 |  |
| Solar Foods | Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes. | $8.6M | Series B | Apr 26, 2024 |  |
| Desentum | Desentum is a research-oriented biopharmaceutical company specialized in developing novel types of allergy vaccines that are based on switching the immune system's response to allergens from hypersensitivity to tolerance. They have a unique approach for designing allergy vaccines. By studying the molecular mechanism of the hypersensitivityreaction, they have made discoveries that allow for improved design of vaccines against common types of allergies. Their goal is to provide long-term relief for patients suffering from allergic symptoms, as well as reduce the social and economic burden allergies cause to both individuals and society. | $12.9M | Venture - Series Unknown | Feb 08, 2024 |  |
| Solar Foods | Solar Foods is a food-tech startup that specializes in testing a technology that uses electricity to produce hydrogen which is combined with carbon dioxide, water, vitamins, and minerals to feed and grow microbial biomass that can be used as edible protein. The industrial biotech startup develops a protein called Solein, a nutritious, sustainablesubstitute for animal-derived proteins. Solein is created using elements from the air—CO2, water, nitrogen—and electricity. This single-cell protein is cultivated through gas fermentation, essentially deriving edible calories from hydrogen-oxidizing microbes. | $8.7M | Series B | Nov 16, 2023 |  |
| Kuva Space | Kuva Space improves life on Earth by using the world's most extensive hyperspectral satellite constellation and artificial intelligence. The company's GREEN DATA® platform will address some of the world's most important concerns, including climate change, disaster response, food demand, and safety and security. | $17.6M | Series A | Nov 02, 2023 |  |
| MedicubeX | MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location. | $1.6M | Seed | May 03, 2023 |  |
| Cerenion | Patented C-Trend technology reveals the status of the brain as one simple score - at the bed-side and without requiring any changes to the care of the patient. The solution works by combining standard EEG-measurement with advanced machine learning algorithms and artificial intelligence. The technology has the potential of improving both the qualityand the cost of intensive care. | $3.6M | Series A | Apr 12, 2022 |  |

10 of 23 investments shown.

## Co-investors
- [Firstminute Capital](https://shizune.co/investors/profile/firstminute-capital) — VC Fund, 2 deals together
- [Maki.vc](https://shizune.co/investors/profile/maki-vc) — VC Fund, 2 deals together
- [10x Founders](https://shizune.co/investors/profile/10x-founders) — VC Fund, 1 deal together
- [Conor Venture Partners](https://shizune.co/investors/profile/conor-venture-partners) — VC Fund, 1 deal together
- [Earth Venture Capital](https://shizune.co/investors/profile/earth-venture-capital) — VC Fund, 1 deal together
- [Elo](https://shizune.co/investors/profile/elo) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SVG Ventures](https://shizune.co/investors/profile/svg-ventures) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Omnivore](https://shizune.co/investors/profile/omnivore-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund
- [Lifeline Ventures](https://shizune.co/investors/profile/lifeline-ventures) — VC Fund
- [Tesi](https://shizune.co/investors/profile/tesi) — VC Fund

## Featured in investor lists
- [All Investors in Finland](https://shizune.co/investors/investors-finland)
- [All VC Funds in Finland](https://shizune.co/investors/vc-funds-finland)
- [Health Care Investors in Finland](https://shizune.co/investors/health-care-investors-finland)
- [Health Care VC Funds in Finland](https://shizune.co/investors/health-care-vc-funds-finland)
- [Biotechnology Investors in Finland](https://shizune.co/investors/biotechnology-investors-finland)
- [Biotechnology VC Funds in Finland](https://shizune.co/investors/biotechnology-vc-funds-finland)

## FAQ

### What does Springvest invest in?

Springvest invests primarily in Biotechnology, Health Care and Medical startups, most often at Series A and Seed stage. Most of the 23 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Springvest's check size?

Springvest typically joins rounds of $1.6M–$7.6M at Seed, $3.6M–$53M at Series A and $9.1M–$29M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Springvest participates in.

### How do I contact Springvest?

Public channels for Springvest include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Springvest?

The team at Springvest includes Aki Soudunsaari (CEO), Jouni Mäkelä (Investment Director) and Markku Jussila (Co-Founder & Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co